New options in the management of intractable ALK(+) metastatic non-small-cell lung cancer.

Lung Cancer (Auckl) · 2014 · PMC5217506 · PMID 28210140

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Although the duration of response is highly significant, the majority of patients will ultimately develop resistance.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.